Eradicazione dell'epatite C nei pazienti emofilici. Tutti i vantaggi dei farmaci rivoluzionari.

    In esclusiva per Haemosafety, il Prof. Massimo Colombo dell'Università degli Studi di Milano, luminare di fama internazionale, mette in luce gli straordinari risultati dei nuovi farmaci contro l'epatite C.

  • 1 August 2016

    Occult HCV Infection: The Current State of Knowledge

    With a clinical history of approximately 11 years, occult HCV infection can be considered an occult type of CHC. Evidences suggest that considering OCI in these high-risk groups seems to be necessary. We suggest that alternative diagnostic tests should be applied and that there is a need for the participation of all countries to determine the epidemiology of […]

  • 29 February 2016

    Viral metagenomics and blood safety

    The characterization of the human blood-associated viral community (also called blood virome) is essential for epidemiological surveillance and to anticipate new potential threats for blood transfusion safety. Currently, the risk of blood-borne agent transmission of well-known viruses (HBV, HCV, HIV and HTLV) can be considered as under control in high-resource countries. However, other viruses unknown […]

  • 29 February 2016

    New viral risks in blood transfusion by 2016

    Viral safety remains a major concern in transfusion of blood products. Over years, the control measures applied to blood products were made more and more sophisticated; however, the number of infectious agents, and notably of viruses, that can be transmitted by transfusion is increasing continuously. The aim of this review paper is to actualize that […]